Mouse CD160 is a MHC I-specific IG-like receptor and positively or negatively regulates NK cell activation, depending on stimuli.
| Institute |
|---|
| BC Cancer |
| SKU: | 157773 |
|---|---|
| Product description: | CD160 is found on cytotoxic lymphocytes – NK, NKT, and activated CD8+ T cells. Mouse CD160 is a MHC I-specific IG-like receptor and positively or negatively regulates NK cell activation, depending on stimuli. |
| Alternate name: | NK28; NK1; BY55 |
| Conjugation: | Unconjugated |
| Molecular weight: | 20 kDa |
| Immunogen: | Mouse CD160 fused to FC |
| Immunogen Uniprot ID: | CD160_MOUSE |
| Myeloma used: | Sp2/0-Ag14 |
| Cat. #: | 157773 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Immunology |
| Application: | FACS ; ELISA ; IP ; WB |
| Target: | CD160 |
| Reactivity: | Mouse |
| Host: | Rat |
| Class: | Monoclonal |
| Target background: | CD160 is found on cytotoxic lymphocytes – NK, NKT, and activated CD8+ T cells. Mouse CD160 is a MHC I-specific IG-like receptor and positively or negatively regulates NK cell activation, depending on stimuli. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Maeda et al. 2005. J Immunol. 175(7):4426-32. PMID: 16177084. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.